FibroBiologics to also present at the BIO CEO & Investor ConferenceHOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- FibroB (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ ...

DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ: NASDAQ:APRE), a biopharmaceutical company with a market capitalization of $21.2 million focused on developing treatments targeting cancer cell ...

Rapid Lock™ is an innovative design that allows for the adjustment of the foot wedge. This mechanism addresses a common ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

By injecting neat or semi-dilute products at the nozzle, the innovative Knight Smart-Inject system provides instant product ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

Attendees will have the exclusive opportunity to experience live demonstrations of VeriQual’s identity verification and ...

Executive orders and other developments suggest changes are in store in the intellectual property (IP) sphere, but the exact shape of the changes ...

This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...